Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Authors:
- P. J. FranklinPFP. J. Franklin
- G. L. HallGHG. L. Hall
- A. MoellerAMA. Moeller
- F. HorakFHF. Horak
- S. BrennanSBS. Brennan
- S. M. StickSSS. M. Stick
- 1 February 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 27 (2) , 350-354
Abstract
Fractional exhaled nitric oxide (FeNO) has been reported to be reduced in cystic fibrosis (CF) patients. However, data from young children are conflicting and it is not clear whether this is a primary feature of the disease or a secondary response. The present study compared FeNObetween CF and healthy infants using a validated single-breath technique.A total of 23 healthy infants (11 females; mean age 40.1 weeks) and 18 infants with CF (nine females; 64.9 weeks) underwent tests of lung function and FeNO. Bronchoalveolar lavage (BAL) was collected from all CF infants 2–5 days after lung function testing.There was no significant difference in FeNObetween the CF and healthy infants (geometric mean: 23.1 parts per billion (ppb) and 17.0 ppb, respectively). There was an inverse relationship between age and FeNOin the CF patients, but not in the healthy group. Within the CF group, there was no association between FeNOand any marker of airway inflammation measured in the BAL.Exhaled nitric oxide is not reduced in cystic fibrosis infants, but does decrease with age. The current data indicate that FeNOis not a good marker of airway inflammation in cystic fibrosis.Keywords
This publication has 21 references indexed in Scilit:
- Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breathThorax, 2004
- NO pathway in CF and non‐CF childrenPediatric Pulmonology, 2004
- Comparison of single-breath and tidal breathing exhaled nitric oxide levels in infantsEuropean Respiratory Journal, 2004
- Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosisThorax, 2004
- Measuring exhaled nitric oxide in infants during tidal breathing: Methodological issuesPediatric Pulmonology, 2003
- Impaired Innate Host Defense Causes Susceptibility to Respiratory Virus Infections in Cystic FibrosisImmunity, 2003
- Exhaled nitric oxide is reduced in infants with cystic fibrosisThorax, 2001
- Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.Journal of Clinical Investigation, 1998
- Airway nitric oxide in asthmatic children and patients with cystic fibrosisEuropean Respiratory Journal, 1996
- Exhaled nitric oxide in paediatric asthma and cystic fibrosis.Archives of Disease in Childhood, 1996